A TGF-beta subtype that plays role in regulating epithelial-mesenchymal interaction during embryonic development. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta3 and TGF-beta3 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor.
Transforming Growth Factor Beta3 has been studied across 17 research domains including 🦴 Bone & Joint, ✨ Skin & Hair, 🔬 Oncology, 🔬 Inflammation, 🫁 Liver & Detox. The primary research focus is 🦴 Bone & Joint with 33% of studies addressing this area.
This evidence profile for Transforming Growth Factor Beta3 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.